contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  createdAt
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
    forum {
      threadUrl
    }
    defaultInstrument {
      symbol
      id
    }
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  createdAt
  changedAt
  isPremium
  authors {
    __typename
    name
    pageUrl
    id
  }
  companies {
    name
    pageUrl
    id
  }
  tags {
    name
    id
  }
  ... on Video {
    liveTime
    videoUrl
    videoEmbedUrl(location: "inderes")
  }
  ... on Webcast {
    liveTime
    videoUrl
    videoEmbedUrl(location: "inderes")
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        threadUrl
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        symbol
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
      researchContentUrl
      researchContent {
        title
        lang
        pdfUrl
        relatedContent {
          __typename
          ...PublishingDetails
          ...Reactions
          id
        }
        content {
          title
          lang
          htmlBody
          publishedAt
          createdAt
          changedAt
          isOutdated
          isPremium
        }
      }
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


atria-negative-impact-from-asf-above-our-earlier-thinking-nordea

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

changedAt

Atria is a food group. The group includes several players, the better known of which include Sibylla, Lithells and Ridderheims. The subsidiaries' operations include the production of liver pâté, meat and chicken products, and various finished products. The operations are conducted on a global level, mainly concentrated in the Nordic countries, the Baltics and Russia. The company was founded in 1903 and has its headquarters in Seinäjoki.

Here are Pauli’s comments on Atria’s release regarding the impacts of swine fever.                    Inderes – 7 Aug 26              Atria: Sikaruton vaikutukset merkittävät, tulos kasvaa silti - Inderes    Yhtiö piti ennallaan nousujohteisen tulosohjeistuksen merkittävästä haitasta huolimatta.

Here are Pauli’s comments on African swine fever and its impact on Atria and HKFoods   African swine fever found in Finnish wild boars will have a negative impact on the export opportunities of the domestic meat industry. An interruption in pork exports to Asia could reduce the companies’ operating profits by an estimated 3-5%.                    Inderes – 31 Jul 26              Atria ja HKFoods: Sikaruton löytyminen heikentää vientituloja - Inderes    Viennin keskeytyminen voisi heikentää jalostajien tuloksia arviolta 3-5 %.

A huge blow to the Finnish meat industry "Atria has activated its contingency plan and is currently not packing products for countries affected by the ASF suspicion regarding exports. According to Hirvijärvi, many Asian countries have a strict stance on African swine fever. According to a press release from the Finnish Food Authority (Ruokavirasto), the infection result is still being confirmed at the European Union reference laboratory for African swine fever in Spain. This is the first time the disease has been detected in Finland. The Food Authority has established an infection zone in Virolahti around the area where the wild boars were found. The movement of pigs kept in the area is restricted. Efforts are being made to prevent the infection from spreading to other parts of Finland. Hirvijärvi also emphasizes that the preliminary ASF finding concerns wild boars, not livestock." “A big and expensive case” The situation also affects products already in transit. “We have hundreds of containers in ports and at sea. There is concern about what will happen to them. Hopefully, they will reach the customers, otherwise, this will become a big and expensive case if the containers have to be turned back,” says Hirvijärvi. According to Hirvijärvi, these are very large volumes of goods, and it is currently being investigated where the products intended for export can now be redirected. “This is definitely a big deal. Vacations have to be canceled, and people have to come in to work.” According to him, exports can only continue to countries with which Finland already has agreed-upon regional restrictions, i.e., regionalization agreements. Currently, from Atria’s perspective, that country is South Korea.

Swine fever has arrived in Finland. - Ruohola estimates that the biggest problems are related to the Chinese and Japanese markets. “It looks like the export ban to China and Japan could last for up to three years. This is a big blow to Finland’s pig farming industry and also to us as a company.” -                   Maaseudun Tulevaisuus – 30 Jul 26              HK Foods: ASF-epäily pysäytti viennin ja uhkaa sulkea Kiinan ja Japanin...    HK Foods on käynnistänyt valmiustoimet afrikkalaisen sikaruton vuoksi ja keskeyttänyt sianlihan viennin. Toimitusjohtaja Juha Ruohola arvioi, että vientikielto tärkeille Aasian markkinoille voi kestää vuosia.

Here is Henri Elo’s article on Atria   The company’s strategic target for return on equity is 12 percent. We wrote about the updated strategy on November 26, 2025. From an investor’s perspective, it is noteworthy that despite ongoing risks, Atria has been able to improve its so-called normal performance. In my view, the new strategy and activity in investments and sales growth, including exports between core markets, support maintaining the earnings level in the future as well. Atria is investing diversely in ready-to-eat food in Finland and Sweden.  Subheadings: 1. Estonia’s most popular food brand is Maks & Moorits  2. New investments again  3. Poultry and ready-to-eat food are growing the market  4. Positive development continues for the sixth year  Note. The author owns shares in the company.  IR-seuranta is a channel by SalkunRakentaja and Sijoittaja.fi’s corporate partners for background and analytical articles as well as other interesting investor information. This article is part of a commercial partnership with the company. The article does not contain investment recommendations.                   SalkunRakentaja – 24 Jul 26              Analyysi: Atria jatkaa investointeja toimintamaissaan – Viron brändiin luotetaan    Atrian hyvätasoinen tuloskehitys jatkuu jo kuudetta vuotta. Uusista investoinneista kerrottiin kesän alussa. Yhtiö alkaa viedä ohukaisia Suomesta Ruotsiin.

Here is a new company report on Atria from Pauli following the Q2 results   Q2 strengthened our confidence in the company’s earnings growth through both the actual figures and the progress made in its strategy. The effects of cost inflation will intensify in H2, but we believe the company will be able to meet the challenge through, for example, pricing. The realization of the guidance, which assumes earnings growth, now appears very likely. The valuation is attractive for a stable earnings grower, so we reiterate our “accumulate” (lisää) recommendation and raise our target price to 19 euros, supported by forecast upgrades (previously €16).                    Inderes              Atria Q2'26: Tulos kasvaa ja pitkän aikavälin hankkeet edistyvät - Inderes    Näemme Ruotsissa useita kiinnostavia kasvuaihioita.

Here are Pauli’s comments on the Q2 result   Atria reported its Q2 results today, which were stronger than expected in terms of both growth and profitability. The figures were boosted by a successful start to the grilling season. The company mentions that cost pressure began to rise toward the summer and expects this to increase during the second half of the year. However, in our view, the company is well-positioned after a strong H1 to achieve its rising earnings guidance. We see the report as slightly stronger than expected overall, which may be reflected in a 3-5% increase in consensus earnings forecasts for the current year.                    Inderes – 22 Jul 26              Atria Q2’26 -pikakommentti: Suomen kasvu siivitti vahvaan tulokseen - Inderes    Grillaussesonki käynnistyi yhtiön mukaan erinomaisesti.

Atria

Atria expects EUR -7m annualised EBIT impact to its Finnish export business from ASF outbreak in Finland. The company assumes that exports to China and Japan will be discontinued while pork ...

Atria expects EUR -7m annualised EBIT impact to its Finnish export business from ASF outbreak in Finland. The company assumes that exports to China and Japan will be discontinued while pork sales to South Korea will continue. Atria expects EUR 4-5m negative impact on 2026 adjusted EBIT but reiterates guidance for higher adjusted EBIT in 2026 (EUR 69.9m in 2025). The impact from ASF outbreak is higher than we had anticipated (low single million) while reiterated guidance point to better-than-anticipated operating performance when excluding Asia exports. We have modelled EUR 74m adjusted EBIT for 2026E. Looking into 2027E, we have anticipated EUR 78m adjusted EBIT (prior to the ASF, LSEG Data &amp; Analytics consensus EUR 74m) and hence EUR 7m impact translates into ~9% impact. However, we believe the company can mitigate part of the impact and note that shares were down 7% last Friday when the first ASF case was published.

Atria: Negative impact from ASF above our earlier thinking - Nordea

Atria: Negative impact from ASF above our earlier thinking - Nordea